Photobiomodulation is the mechanism by which non-ionizing optical radiation in the visible and near-infrared spectral range is absorbed by endogenous chromophores to elicit photo-physical and photo-chemical events at various biological scales. Photobiomodulation Therapy (PBMT) is a form of light therapy based on the principles of photobiomodulation. It involves the use of light sources including lasers, LEDs, and broadband light, in the visible and infrared spectrum to cause physiological changes and therapeutic benefits. PBMT has the potential to revolutionize modern healthcare and is being used by veterinarians, dentists and physical therapists for a number of applications including tissue regeneration, pain relief and regulation of inflammation. New areas of research include as age-related macular degeneration, spinal cord injury, and traumas and pathologies of the brain. The focus of the OSA Photobiomodulation Technical Group will be to develop guidelines to help ensure safety, efficacy and scientific accuracy in photobiomodulation research and technology development.
||U.S. Food and Drug Administration||Chair
||LiteCure, LLC||Vice Chair
||University of Otago||PBM Applications Officer
|| ||Publications Officer
||Curative Sciences||Social Media Officer
||University at Buffalo||Webinar Officer
05 - 09 July 2021
Dijon Convention Center (Congrexpo)
31 - 04 November 2021
District of Columbia
If you are a member of the Photobiomodulation Technical Group and have ideas for activities and initiatives to help engage this community, please share them with the chair, Ilko K. Ilev.
View OSA Technical Group webinars on-demand at any time or register for any of our upcoming webinars online. Each webinar is an hour long and features a technical presentation on a topic selected by your OSA Technical Groups.
Join our Online Community